Hyponatremia in Patients with Cirrhosis of the Liver

Clinical practice guideline on diagnosis and treatment of hyponatraemia

(2014) Goce Spasovski et al.   INTENSIVE CARE MEDICINE

Terlipressin therapy for moderate-to-severe hyponatraemia in patients with liver failure

(2012) E. Prakoso et al.   INTERNAL MEDICINE JOURNAL

Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites

(2012) Thomas Sersté et al.   JOURNAL OF HEPATOLOGY

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

(2012) Vicente E. Torres et al.   NEW ENGLAND JOURNAL OF MEDICINE

Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity

(2011) Florence Wong et al.   GUT

Albumin infusion in patients undergoing large-volume paracentesis: A meta-analysis of randomized trials

(2011) Mauro Bernardi et al.   HEPATOLOGY

Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis

(2011) Andrés Cárdenas et al.   JOURNAL OF HEPATOLOGY

Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis

(2010) Florence Wong et al.   JOURNAL OF HEPATOLOGY

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis

(2010)   JOURNAL OF HEPATOLOGY

Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner?

(2010) Maurizio Biselli et al.   LIVER TRANSPLANTATION

Organic osmolytes in hyponatremia and ammonia toxicity

(2010) Jessica Heins et al.   METABOLIC BRAIN DISEASE

Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence

(2010) Juan Córdoba et al.   METABOLIC BRAIN DISEASE

Hyponatremia Is a Risk Factor of Hepatic Encephalopathy in Patients With Cirrhosis: A Prospective Study With Time-Dependent Analysis

(2009) Mónica Guevara et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Impact of pretransplant hyponatremia on outcome following liver transplantation

(2009) Byung Cheol Yun et al.   HEPATOLOGY

Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease

(2009) Jacqueline G. O'Leary et al.   LIVER TRANSPLANTATION

Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized Study

(2008) Marta Martín–Llahí et al.   GASTROENTEROLOGY

A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal Syndrome

(2008) Arun J. Sanyal et al.   GASTROENTEROLOGY

Effects of satavaptan, a selective vasopressin V2receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: A randomized trial

(2008) Pere Ginès et al.   HEPATOLOGY

Hyponatremia in cirrhosis: Pathogenesis, clinical significance, and management

(2008) Pere Ginès et al.   HEPATOLOGY

Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List

(2008) W. Ray Kim et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hepatic Encephalopathy

(2008) Juan Córdoba et al.   SEMINARS IN LIVER DISEASE